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Abstract 
The influence of three functionalized hexavanadates (V6): Na2 [V6O13{(OCH2)3CCH3}2], [H2]2  
[V6O13{(OCH2)3CCH2OCOCH2CH3}2] and [(C4H9)4N]2  [V6O13{(OCH2)3CCH2OOC(CH3)2-
COOH}2 on Na+/K+-ATPase activity, was investigated in vitro. Including compounds already 
tested by Xu et al. (Journal of Inorganic Biochemistry 161 (2016) 27–36), all functionalized 
hexavanadates inhibit the activity of Na+/K+-ATPase in a dose-dependent manner but with 
different inhibitory potencies. Na2 [V6O13{(OCH2)3CCH3}2] was found to have the best 
inhibition properties - showing 50 % inhibition IC50 = 5.50 × 10-5 M, while [(C4H9)4N]2  
[V6O13{(OCH2)3CCH2OOC(CH3)2-COOH}2] showed the lowest inhibitory power, IC50 = 1.31 × 
10-4 M. In order to understand the bioactivity of functionalized hexavanadates serie, we have 
also used a combined theoretical approach: determination of electrostatic potential from ab 
initio theoretical calculations and computation of the molecular interaction field (MIF) surface. 
 
Highlights 
• Functionalized hexavanadates inhibit Na+/K+-ATPase in a concentration-dependent manner. 
• Na2 [V6O13{(OCH2)3CCH3}2] is the strongest investigated hexavanadates inhibitor. 
• Negative electrostatic potential is an indicator of inhibition character. 
• Molecular interaction field surface allows predictions of inhibition character.  
• The largest negative molecular interaction field concerns the nitro- hexavanadate. 
 
Key-words 
Functionalized hexavanadate, Na+/K+-ATPase, Inhibition, Electrostatic potential, Molecular 
Interaction Field 
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Graphical abstract 
 
 
The inhibition character on Na+/K+-ATPase of three functionalized hexavanadates have been 
determined. Using ab-initio calculations and molecular interaction field five criteria have been 
established to understand the inhibition potentiality of nine functionalized hexavanadates. The 
best criterion is the ratio of negative area of molecular interaction field over its molecular 
surface. 
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1. Introduction 
Polyoxovanadates (POVs) is a rapidly growing family of vanadium oxide molecular anions, as 
attested by the occurrence progression in Web of Knowledge© (Figure S1). They exhibit 
interesting structures and offer extensive potential applications in material science and 
medicinal chemistry [1-11]. Polyoxometallates (POMs) possess important biological and 
pharmacological attributes such as antiviral, antibacterial and anticancer properties which are 
most probably based on their interactions with diverse biomacromolecules [12-17]. The 
Lindquist type alcohol hexavanadates (that we should refer to as V6) are the largest subclass of 
the POV derivatives, in which the hexavanadate core {V6O19} is stabilized by tridentate ligands 
(OCH2)3R (R = -CCCH3, -CNO2, -CCH2OH, ...). The pioneer investigations of these derivatives 
were mainly conducted by Zubieta [18-20] and Müller [21]. In recent years, some 
functionalized V6 have been synthesized [22-25].  
The biological activity of decavanadate (V10) had been extensively reviewed [6-7, 10-11, 26] 
with potential use in anticancer [27-28] anti-diabetic therapies [29-30] and antibacterial activity 
[31]. V10 is known to modulate the activity of many proteins such as phosphatases [32],, myosin 
[33-34] and calcium pump ATPase  [35-36] and to interact with proteins such as actin [26, 37, 
38]. New POVs have antifungal activities against Candida species [39-40]. 
The most frequent interactions between POMs and biomacromolecules are electrostatic 
interactions and hydrogen bonds. Apart from the interactions between POMs and proteins, size 
and shape of the POM in some cases play a tremendous role [8, 41]. A key to success and 
further progress in this field is a detailed understanding of the protein-ligand interactions. The 
description of a molecule and its influence on the surroundings is useful information to explain 
and understand chemical reactions and bio-chemical interactions. Depending on the different 
fields, there are several ways to define the interaction force of a molecule with a protein or a 
receptor, such as lipophilicity, polarizability, electronic properties and steric interactions. An 
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efficient and elegant method for predicting ligand binding sites would involve the use of a 
molecular docking software such as GRID [42] designed by Molecular Discovery©. GRID is 
used to study the energetically favorable binding sites of molecules of known structures. A 
binding surface on a protein is understood through the definition of an interaction energy for a 
probe group or compound. It then allows that probe to sample all possible sites on the surface 
of the protein until a set of potential energy minima is found. As a consequence, these minima 
represent sites at which the probe could react favorably with the protein under study [43].  
Recently, we have found that POVs exhibit inhibitory influence on Na+/K+-ATPase activity 
[44-45] which is a cell membrane located enzyme. Such enzyme establishes and maintains the 
high internal K+ and low internal Na+ concentrations, characteristic and essential for normal 
cellular activities of most animal cells [46-47]. The activity of this enzyme is very sensitive to 
the presence of some metal ions and organic compounds of various structures, especially some 
drugs and pesticides [48-51]. Inhibitions of several ATPases such as P-type ATPases, ABC-
ATPases and ribonucleases by decavanadate suggest that V10 interactions with these proteins 
are probably favored by the existence of an ATP binding site [52-54]. Considering the key role 
of Na+/K+- ATPase in normal functioning of most animal cells, as well as its pivotal role in 
cancer cell migration, the aim of this work is to examine the influence of three hexavanadates 
(namely: Na2 [V6O13{(OCH2)3CCH3}2] as referred to compound (1-Na) [20], [H2]2  
[V6O13{(OCH2)3CCH2OCOCH2CH3}2] (2-H) [55] and [(C4H9)4N]2  
[V6O13{(OCH2)3CCH2OOC(CH2)2-COOH}2] (3-TBA) [56] where TBA [(C4H9)4N] is the 
counter cation) on Na+/K+- ATPase activity, using commercially available Na+/K+- ATPase 
from porcine cerebral cortex as a model system. Numbering of the compounds indicates the 
different functionalization (different anions), while the counterions are indicated when 
necessary (see abbreviation section).  
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In this paper, we suggest a combined approach to investigate the reactivity and to understand 
the bioactivity of functionalized V6 serie involving the theoretical electrostatic potential (EP) 
from ab initio theoretical calculation, and molecular interaction field (MIF) determination. In a 
previous paper [45], we have studied the reactivity of four V6 anions (2, 3, 8, 9) using the 
electrostatic potential values at the molecular surface. In the present work, we have determined 
EP values at the molecular surface of the other functionalized V6 serie (5, 6, 7). For all V6 
anions (1 to 9) and V10 anion (10) (see table S1 in supporting information) we have calculated 
the stabilization energy from ab initio calculation and determined the MIF. Understanding 
protein-ligand interactions is essential in drug design. Therefore, experimental results will be 
compared with theoretical ones generated from the molecular docking software GRID in order 
to determine if our methods suggest similar binding ways i.e. position and orientation of the 
ligand. 
 
2. Materials and methods  
2.1.  Preparation of V6 solutions 
Synthesis of 1-Na has been published by Chen et al. [20], 2-H by Wu et al. [55] and 3-TBA by 
Xiao et al. [56]. Stock solution (0.1M) of 3-TBA was prepared by dissolving the solid 
compound in DMSO, while 1-Na and 2-H stock solutions were prepared in water. Working 
solutions were prepared daily by diluting the stock solutions with water to the desired 
concentrations, shortly before use.  
 
2.2.  Na+/K+-ATPase assay 
Na+/K+-ATPase from porcine cerebral cortex was purchased from Sigma Chemicals Co.® 
(Germany). Final DMSO volume fraction in the incubation medium did not exceed 1%. The 
activity of Na+/K+- ATPase was followed in the absence (control) and presence (during 20 min) 
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of increasing V6 concentrations by monitoring spectrophotometrically (Perkin Elmer® Lambda 
35 UV-VIS spectrophotometer) the released Pi liberated from the enzymatic hydrolysis of ATP 
[57].  
 
2.3.  Computational details: Ab initio calculations 
Density functional theory (DFT) calculations were performed with Gaussian 09 (EM64L-
G09RevC.01) [58]. Different functionals and basis sets have been employed (Table S2) 
depending on the calculation (EP or charges). All belong to the hybrid functionals family, and 
therefore include a mixture of Hartree-Fock exchange with DFT exchange-correlation (B3LYP 
[59], M06/M06-2X [60], B3PW91 [61]). The basis sets take into account polarization and 
diffuse functions (6-31+G(d, p) [62], 6-311+G(d, p) / 6-311++G(d, p) [63], cc-pVTZ [64]). The 
atomic coordinates of 10 [65], 9 [66], and 3[67] anions are obtained from the corresponding 
high resolution X-ray diffraction nuclei positions, without geometrical optimization. Atomic 
coordinates of other V6 serie are obtained from Cambridge Structure Database (CSD). Refcodes 
and references are given in Table S1. The geometry has been optimized within the M06/6-
31+G(d, p) quantum chemical model. The computed densities have converged at cc-pVTZ 
level, except for 5, which has converged at 6-311+G(d, p) level because of computation time 
constraints. Due to disorder on one organic chain, no EP has been determined for 3. Only a 
density has been computed in order to estimate the volume and the area at the molecular surface. 
All figures have been obtained using Molekel [68]. 
Converged ab-initio results are then used to compute topological properties and indicators in 
in the framework of Bader's Quantum Theory of Atoms in Molecules theory using a dedicated 
computer code AIMALL (Version 14.11.23) [69].  
 
2.4. Computational details: molecular interaction field 
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The interaction of the probe group (H2O, OH, NH, CH3, metal,...) with the target (the drug or 
the inhibitor) is computed at sample positions (the grid points) distributed throughout and 
around the molecule [42]. With the probe at each GRID [70] point in turn, the total interaction 
energy is calculated from:  
!𝐸 = 𝐸$%		 + 	𝐸(	 +	𝐸)*		 + 	𝐸+		 
 Eq. (1) 
In this formula:  
- ∑E indicates pairwise energy summation between the probe at its grid points and every 
appropriate atom of the target (including predicted water molecules);  
- ES is the appropriate entropic term at the grid points introduced by the authors [71] to take 
into account when parts of the target are treated as flexible or when the probe interactions are 
compared to that of water, and for the hydrophobic probe;  
- The ELJ term is the well-known “Lennard-Jones energy”, and is computed as the sum of two 
terms: 
 Eq. (2) 
d is the inter-atomic distance, and the energy variables A and B are calculated from the Van der 
Waals radius, polarizability and effective number of electrons of the atoms (ELJ = EVDWR);  
- EQ is the electrostatic term and EHB is the standard hydrogen bond interaction.  
We used an unstable development release of GRID software [70] to parametrize V2+ in the 
target, due to the fact that the commercial version is only configured for vanadium as a probe. 
The impossibility to constrain the total charge on the molecules implies that the results mapped 
on the molecular surface (as determined from ab initio calculations) are presented in arbitrary 
unit (a.u.) which should be kcal.mol-1. The figures presented in this paper have been done using 
Chimera [UCSF Chimera, version 1.13.1]. 
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3. Results and discussions 
3.1. In vitro influence of V6 compounds on Na+/K+- ATPase activity 
In a previous paper [45], we have studied in vitro influence of five functionalized V6 (1-TBA, 
2-TBA, 7-TBA, 8-TBA and 8-Na) on the commercial porcine cerebral cortex Na+/K+- ATPase 
activity. In this study, the influence of three other functionalized V6 compounds (1-Na, 2-H, 3-
TBA) on Na+/K+- ATPase activity was investigated in the concentration range 1×10-8 - 1×10-3 
M. The enzyme activity, expressed as a percentage of the control value (obtained without 
inhibitor), decreases in the presence of increasing V6 concentrations, showing a monophasic 
sigmoidal curve for all cases (Figure 1a).  
The inhibition parameters, the concentration of the investigated compounds with capability to 
inhibit 50 % of the enzyme activity after given exposure time (IC50) and Hill's coefficient (nH), 
were determined using the Hill's analysis (Figure 1b) and are summarized in Table 1. Our 
results indicate that all investigated compounds inhibit the Na+/K+ ATPase activity in a dose-
dependent manner, but with different inhibiting potencies. 1-Na (IC50 = 5.50 × 10-5 M) was 
found to be the best inhibitor of Na+/K+ ATPase activity, while 3-TBA showed the lowest 
inhibitory potency (IC50 = 1.31 × 10-4 M) (Table1). The calculated nH values (nH < 1) suggest 
that there is no positive cooperativity inV6 binding relative to the enzyme (see Table 1). 
Those results are in agreement with the concentration-dependent inhibitory effect of POVs on 
synaptic plasma membrane and commercially available porcine cerebral cortex Na+/K+ ATPase 
already reported [44-45]. Table 2 contains the inhibition results for eight investigated V6 (three 
compounds in this work and five ones previously reported); the counterion is indicated. Our 
results demonstrate that the inhibitory effect on Na+/K+-ATPase activity leads to the following 
ranking: 7-TBA > 8-TBA > 1-TBA > 2-TBA > 1-Na ~ 2-H > 3-TBA >  8-Na. As a matter of 
fact, the most potent inhibitor is compound 7-TBA (IC50 = (1.8 ± 0.5) × 10-5 M), while the 
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compounds 8-TBA, 1-Na, 2-TBA and 1-TBA are significantly weaker inhibitors of Na+/K+-
ATPase. Three anions have been tested with different counter cations: 1-TBA, 2-TBA and 8-
TBA with TBA, while 1-Na and 8-Na where prepared with [Na]+; and 2-H with [H]+. It is 
interesting to observe that both compounds 8-TBA and 2-TBA, synthesized with TBA as a 
counter cation, have lower IC50. The last compound 1-Na is in the interval errors. This would 
suggest that small cations such as sodium or proton could interact with Na+/K+- ATPase and 
prevent the inhibition action of V6. Therefore, taking into account the inhibition parameter with 
the same counter cation (TBA), we observe the following ranking: 7-TBA > 8-TBA > 1-TBA 
> 2-TBA > 3-TBA. From simple chemical eyes, it seems that an additional negative charge on 
nitro- 7-TBA or alcoholic groups 8-TBA results in stronger enzyme inhibition. 10-NH4 is up 
to approximately two hundred times more potent inhibitor of the purified enzyme (IC50 = 1.71 
× 10-6 M) [44] than the investigated V6 compounds. This is in agreement with the fact that all 
the functionalized V6 anions bear a formal charge of -2, while V10 is described with a formal 
charge of -6. The experimental electron density determination on 2-TBA in solid state, and its 
interpretation via integrated source function, give only 5.5 % of  charge transfer from cation to 
anion [67]. In solution state, the functionalized V6 and V10 anions are stable [72]. 
Although a few different isoforms of brain Na+/K+-ATPase have been known [44], the obtained 
monophasic inhibition curves do not suggest the heterogeneity of the V6 binding sites. This is 
in agreement with previously published findings related to POM-induced inhibition of different 
types of ATPases [44-45, 51]. 
Hexavanadate V(V) derivatives are susceptible to hydrolysis and not stable in water [73]. When 
the valence state involves (V4+) species, it comes to be stable against hydrolysis. It should be 
no problem because the activity is far below the decavanadates and this decomposition should 
be minor. 
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3.2. Ab initio calculations 
In order to interpret the differences we have observed in inhibition activities of POVs and so as 
to complete our investigation, ab initio calculations (the energy of stabilization and theoretical 
EP) were carried out for different V6 anions (Table S2). 
Reactivities of four V6 anions (1, 2, 7 and 8) using EP values at the molecular surface have 
already been investigated in a previous work [45]. We have now determined EP values at the 
molecular surface of the other functionalized V6 anions (4, 5, 6 and 9) and for the V10 anion 
(10). The quality of these ab initio calculations is established through the comparison of the 
experimental EP mapped on the molecular surface of 10 determined previously [65] with the 
theoretical one (Figure 2, first line). The excellent agreement brings legitimacy to a precise 
interpretation of ab initio results on the V6 serie.  
In order to graphically exhibit the intermolecular charge transfer, between V6 core and the 
organic ligand, iso-surfaces of EP are mapped (iso-value surface at ± 0.40 eÅ-1) for anions 1 
(Figure 3), 7 (Figure 4), 2 (Figure 5), 9 (Figure 6), 6 (Figure S3), 4 (Figure S4), 5 (Figure S5), 
8 (Figure S6). The qualitative observation of the EP indicates that V6 have two hydrophobic 
heads and an hydrophilic hexavanadate core. The red part (negative) is localized around the V6 
core, which corresponds to the most nucleophilic regions, while the blue part (positive) is 
concentrated over the organic ligand and represents the most electrophilic regions. The EP 
values are the most negative in the vicinity of the three oxygen atoms. It provides a predictable 
pattern for noncovalent interactions and figures out the probable chemical reaction sites. In this 
type of functionalized V6 compounds, O1x (bonded to only one tungsten atom) and O2x (shared 
between two tungsten atoms) are potential reaction sites [21, 74, 75]. Moreover, three anions 
6, 7 and 8 present an extension of the nucleophilic region on the organic chain. These negative 
regions are in the vicinity of heteroatoms (oxygen or carbon). A selection of quantitative 
parameters is reported in Table 2. This extension is not directly connected to the number of 
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heteroatoms on the organic chain, but it is the signature of amino-, nitro-, hydroxy, pyridyl- 
chemical groups. Compounds which present an ester group do not exhibit negative EP in the 
vicinity of their oxygen atoms. In order to explain the differences in term of inhibition for the 
compounds studied in this paper, we make the hypothesis that a negative contribution will 
favorize inhibition. Therefore, in the following discussion we will examine some criteria which 
could have an impact on their inhibition potencies. According to the criterion, “a negative EP 
extension surface on the organic chain” that we will refer to as criterion I, anions 6, 7 and 8 
would be better inhibitors than the others (no results on 5).  
Atomic net charges are obtained for short and long functionalized V6 serie by integration on 
atomic basins following the method of QTAIM (Table S3). Charges of V atoms are in a narrow 
range, from +2.333 e to +2.483 e. Summations of AIM charges for V6 core are maintained 
around -5.2 e although the organic ligands are chemically different. Therefore, the criterion 
“theoretical atomic net charges values” that we will refer to as criterion II, would not be a 
pertinent criterion for explaining the different inhibition values for the V6 serie. 
 
3.3. Molecular interactions field calculation 
MIF surfaces for seven V6 and for V10 indicating the place of preferential interactions between 
vanadate and water have been determined. MIF values are presented as positive and negative 
iso-surfaces (second line, left of the figure) and are also plotted on the molecular surface 
(second line, right of the figure) for the following anions: 1 (Figure 3), 7 (Figure 4), 2 (Figure 
5), 9 (Figure 6), 6 (Figure S3), 4 (Figure S4), 5 (Figure S5) and 10 (Figure 2). Iso-surface 
positive MIF (in red on the figures) mimic the possible interaction localization between protons 
of the active site of the Na+/K+-ATPase and functionalized V6. According to the criterion, “a 
negative MIF extension on the organic chain”, that we will refer to as III, anions 6, 7, 2, 9 and 
4 would be better inhibitors than the others. 
 13 
In order to quantify the extension of these surfaces, volumes and areas (at the values indicated 
in the Figures) are reported in Table 2. A larger surface would be favorable to interactions. 
According to the criterion, “a MIF surface area value” that we will refer to as IV, V6 serie could 
be ranked as follows: 9 >> 10 >> 4 > 5 ~ 6 ~ 2 >> 1. It leads to the prediction that 9 would be 
the best inhibitor (no results on 8 and 3). 
In Figure 2, the EP mapped on molecular surface of 10 gives a range of colors leading us to 
distinguish the different oxygen atoms and determine which oxygen atom would be 
preferentially involved in the interaction (in solid state as well as in solution state) [76]. In 
contrast to MIF mapped on the same molecular surface, differences cannot be distinguished 
between the oxygen atoms of V10. For the V6 compounds, the molecular surface is divided into 
two areas: the positive MIF (blue part) and the negative MIF (red part). There is no smooth 
transition between these two areas. However, as for EP, the values of MIF (Figure S3, second 
line left and right) at greater distance (as depicted by the iso-surface) indicates the contribution 
of nitrogen atom to the prediction of interaction (see for example compound 7).   
 
3.4. Interpretation of the inhibition results combining EP and MIF results 
According to the three methods (IC50, EP, MIF) used in this paper to study the potential 
inhibiting power of POVs on Na+/K+-ATPase activity, we have been able to draw some 
conclusions which are summarized in Table 3 and presented graphically in Figure 7. As 
observed previously, small counter cations could bind to the protein and therefore perturbate 
the influence of the organic substituent on a V6 serie. Therefore, we have decided to retain for 
our conclusions only the experiments performed with TBA as a cation. Their IC50 values are 
reported in orange in Figure 7. Examination of EP have been done via observation of negative 
EP extension on organic chain. Favorable criterion I is indicated in the column with the symbol 
(ü), while unfavorable criterion I appears in the column with the symbol (û). This is graphically 
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indicated on the right part of Figure 7 (green bars). The two first better inhibitors verify criterion 
I. Similarly, qualitative observation of the MIF extension in the vicinity of the organic part 
(criterion III) is also shown on the right part of Figure 7 (red bars). There is no correlation with 
the inhibition behavior of the three compounds (7-TBA, 2-H and 1-Na) for which we have IC50 
and criterion III information. Criterion IV for the V6 serie has been reported in Table 2 and in 
Figure S7 (grey bars). There is still no correlation with the inhibition values.  
In order to normalize this area with respect to the size of the different anions, a ratio (negative 
MIF iso-surface at 2 Kcal.mol-1 over the molecular surface area) is calculated (Table 2). Those 
ratios are displayed in the center of Figure 7 (blue bars) and is refer to as criterion V. 
Compounds have been ranked according to this ratio (top the greatest ratio, to the smallest on 
the bottom). The expected correlation is now rendered for the three V6 anions (7, 2 and 1) and 
for 10. Those four anions are the ones for which we have both information: the greater the ratio, 
the better the inhibitor. In other word, it means that smaller compounds exhibiting larger 
negative region for interactions are expected to be better inhibitors. The last two anions for 
which MIF could not be computed (for technical reasons) have been placed in Figure 7 
according to their IC50 values.  
Now, we can observe the organic radical R (left part of Figure 7) from the 
[V6O13{(OCH2)3R}2]2- anion formula. This allows us to predict which compounds would be 
good inhibitors. Our recommendation would be to use an amino- group on a small organic chain 
such as compound 6-TBA. Comparisons between 2-TBA, 4-TBA and 5-TBA indicate that a 
longer chain should decrease the inhibition potential. A large compound with many 
heteroatoms such as 5-TBA gives a large extension of negative MIF over the organic chain, but 
a smaller ratio. Therefore, it should not be a good inhibitor.  
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4.  Conclusion 
From a methodological point of view, the goal of this work was to use the MIF tool as a bridge 
between experimental inhibition results and sophisticated CPU time consuming ab initio 
computations. Our results have demonstrated that EP iso-surface would be good criterion to 
classify interactions, but it did not provide any ranking. A combination of fine quantitative 
analysis of MIF results and ab initio calculations allowed us to interpret and predict the potential 
inhibitor character of a V6 series. 
From a biochemical point of view, we can conclude that the tested functionalized V6 
compounds exhibit concentration-dependent inhibitory effect on Na+/K+-ATPase activity. The 
inhibitory potencies of this V6 series toward Na+/K+-ATPase are weaker (about two orders of 
magnitude) related to V10. Size of 10 is smaller than the functionalized V6, which indicates that 
10 can easily access to the binding site of the receptor. The most hydrophilic EP and MIF iso-
surface concerns anion 7. This small anion has negative charge around the two heads and the 
higher affinity toward (positively charged) protein regions. Our results confirm that the 
differences in the inhibition power are due to different charges, sizes and shapes of these V6, 
and more precisely to the ratio of a hydrophilic region area normalized with their molecular 
surface area of the whole molecule.  
It is well known that a monomeric orthovanadate is bound to the catalytic site of P-type 
ATPases, acting as a transition-state analog of phosphate, and consequently inhibits the enzyme 
activity at nanomolar concentrations [77, 78]. Because the investigated polymeric vanadates 
exhibit weaker inhibitory potencies (at micromolar concentrations), it seems that the enzyme 
active site is not directly involved in the inhibition by the polymeric species. In other words, 
the enzyme activity is modified due to the interaction of the polymeric vanadates with binding 
sites different from the active one. 
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A better understanding of POMs – protein interaction may be useful to elucidate the biological 
activities of the POMs in order to make them available and safe for clinical use. This approach, 
which combines ab initio calculations, semi-empirical computations and experimental 
inhibition studies, contributes to finding a potential and at the same time selective and specific 
Na+/K+-ATPase inhibitor, one of the key enzymes in the functioning of a healthy cell and 
development of pathological conditions. 
 
Supporting information 
Table S1. Compounds cited in this work; Table S2. Computational details tested in this work; 
Table S3. Theoretical AIM charge; Figure S1. Progression of the polyoxovanadate and 
hexavanadate; Figure S2. Three models of V6 DFT calculations; Figure S3. Electrostatic 
potential (EP) and molecular interaction field (MIF), water probe on anion 6; Figure S4. 
Electrostatic potential (EP) and molecular interaction field (MIF), water probe on anion 4; 
Figure S5. Electrostatic potential (EP) and molecular interaction field (MIF), water probe on 
anion 5; Figure S6. Electrostatic potential (EP) of anion 8; Figure S7. Comparison of IC50 values 
with two criteria deduced from the MIF analysis; Figure S8. Powders of the functionalized V6 
serie. 
 
Abbreviation 
 
Numbering of the compounds is an association of a number (the POV anions) and a group of 
letters (the counter cation). When a fictive anion is concerned (for EP and MIF), the 
corresponding number (without letters) is given in the text.  
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1-Na = Na2 [V6O13{(OCH2)3CCH3}2] 
1-TBA = [(C4H9)4N]2  [V6-O13{(OCH2)3CCH3}2] 
2-H = [H2]2  [V6O13{(OCH2)3CCH2OCOCH2CH3}2] 
2-TBA = [(C4H9)4N]2  [V6O13{(OCH2)3CCH2OCOCH2CH3}2] 
3-TBA = [(C4H9)4N]2  [V6-O13{(OCH2)3CCH2OOC(CH3)2COOH}2 
4-TBA = [(C4H9)4N]2  [V6O13{(OCH2)3CCH2OOC(CH2)4CH3}2] 
5-TBA = [(C4H9)4N]2  [V6O13{(OCH2)3CCH2OOC(CH2)16CH3}2] 
6-TBA= [(C4H9)4N]2  [V6O13{(OCH2)3CNH2}2]· 
7-TBA = [(C4H9)4N]2  [V6O13{(OCH2)3CNO2}2] 
7-TBA-CH2Cl2 = [(C4H9)4N]2  [V6O13{(OCH2)3CNO2}2] 0.67(CH2Cl2) 
8 -TBA= [(C4H9)4N]2  [V6O13{(OCH2)3CCH2OH}2] 
8-Na = Na2 [V6O13{(OCH2)3CCH2OH}2] 
9-TBA = [(C4H9)4N]2  [V6O13{(OCH2)3CNHCOC15N3}2] 
10-NH4 =  (NH4)6 [V10 O28] . 5H2O 
10-Cyt =  Na3 [V10 O28] (C4N3OH5)3(C4N3OH6)3 
 
  
CSD = Cambridge Structure Database  
DFT = density functional theory 
EP = electrostatic potential 
MIF = molecular interaction field 
POM = polyoxometalate 
POV = polyoxovanadate 
V10 = decavanadate 
V6 = hexavanadate 
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Table caption 
 
Table 1. The inhibition parameters of hexavanadates for Na+/K+ - ATPase obtained by Hill 
analysis; IC50 is the concentration of the investigated compounds with capability to inhibit 50% 
of the enzyme activity. 
Table 2. Geometrical, MIF and inhibition parameters of V10 and a set of functionalized V6. 
Compounds are separated in three groups (between the bold lines) V10, short V6, long V6. 
Number of carbon atoms (second column) and heteroatoms (third column) contained in the 
organic chain. Geometrical parameters: longest length between two atoms of the organic chain 
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(fourth column); volume (fifth column) and area (sixth column) occupied by the electron 
density at the molecular surface (0.00007 eA-3) as determined via ab initio calculations. MIF 
parameters: area (seventh column) of the negative surface at -2 kcal.mol-1 for V6 and -0.7 
kcal.mol-1 for V10; ratio (eighth column) of the MIF negative iso-surface over molecular surface 
area. IC50 inhibition parameters (M): the different columns correspond to the different cations 
used to stabilize the anions in the inhibition experiments. Some values have already been 
published and are indicated a [44] b [45]. 
Table 3. Summary of the inhibition results or predictions obtained with the different methods 
used in this work.  
 
Figure caption 
Figure 1. (a) Concentration-dependent inhibition of Na+/K+-ATPase activity induced by three 
functionalized hexavanadates. The values are expressed as mean ± S.E.M; (b) Hill analysis of 
Na+/K+-ATPase activity inhibition induced by three functionalized hexavanadates. 
Figure 2. Experimental, theoretical electrostatic potential (EP) and molecular interaction field 
(MIF) with water probe on anion 10. Experimental EP (10-Cyt) is reproduced with permission 
of reference [65]. 
Figure 3. Electrostatic potential (EP) (Gaussian/M06/cc-pVTZ) and molecular interaction field 
(MIF), water probe on anion 1. EP is reproduced with permission of reference [45]. 
Figure 4. Electrostatic potential (EP) (Gaussian/M06-2X/cc-pVTZ) and molecular interaction 
field (MIF), water probe on anion 7. EP is reproduced with permission of reference [45]. 
Figure 5. Electrostatic potential (EP) (Gaussian/M06-2X/cc-pVTZ) and molecular interaction 
field (MIF), water probe on anion 2. EP is reproduced with permission of reference [45]. 
Figure 6. Electrostatic potential (EP) (Gaussian/M06-2X/cc-pVTZ) and molecular interaction 
field (MIF), water probe on anion 9. 
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Figure 7. Comparison of experimental inhibition parameter (IC50 * 1000) for the V6 compounds 
stabilized with TBA as a counter cation with the ratio (eighth column of Table 2) of the MIF 
negative iso-surface over molecular surface area (criterion V). The organic ligand is given 
besides the anion number. Two colored lines indicates the trend. Compounds were ranked 
according to their ratio values. When the value does not exist the compounds have been inserted 
according to their IC50 value. Criteria on the negative extension of negative EP criterion I) or 
MIF iso-surface (criterion III) are indicated on the right part of the figure. It has to be noticed 
that due to the construction of this figure, one cannot predict the relative inhibition potential 
between the group 4 > 9 > 5 and 3 which could be inserted at any position in this series in this 
ranking.  
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Table 1.  
 
Compound 
Structure of functionalized 
hexavanadates 
IC50, M nH 
1-Na  
(5.50  ± 0.28) × 10-
5 
0.44 
2-H 
 
(1.05 ± 0.05) × 10-4 0.98 
3-TBA 
 
(1.31 ± 0.06) × 10-4 0.99 
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Table 2.  
 
Compound 
Geometrical 
parameters 
MIF IC50 
anion 
N
um
. C
 
N
um
 N
 or O
 
length (Å
) 
V
olu m
e  (Å
3) 
A
rea (Å
2) 
A
rea (Å
2) 
ratio  
T
B
A
 
N
a  
H
 
N
H
4  
10 0 0 9.9 655 542 644 1.19 
   
1.71*10-
06 b 
6 0 1 11.1 323 495 559 1.13 
    
1 1 0 11.3 316 334 212 0.63 
0.000076 
a 
0.00005
5  
  
7 0 3 12.5 355 512 538 1.05 
0.000018 
a 
   
8 1 1 12.9 354 498 
  
0.000029 
a >0.001a 
  
2 4 2 16.5 467 737 555 0.75 
0.000055 
a 
 
0.00010
5 
 
4 7 2 16.7 1074 944 573 0.61 
    
3 5 4 18.5 498 786 
  
0.000131 
   
9 16 5 27.3 916 1396 773 0.55 
    
5 19 2 54.7 1355 1849 562 0.30 
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Table 3  
 
Criteria Favorable Unfavorable Non tested 
Exp. IC50 (all compounds) 
10-NH4 >> 7-TBA > 8-TBA > 1-TBA > 2-TBA 
> 1-Na ~ 2-H > 3-TBA >  8-Na 
4-TBA, 5-TBA, 6-
TBA, 9-TBA and 
10-Cyt 
EP 
I EP extension 6, 7 and 8 1, 2, 4, 5 and 9 3 
II Atomic net charges no effect 3 and 5 
MIF 
III MIF extension 2, 4, 6, 7 and 9 1 and 5 
8 and 3 
IV MIF surface 9 >> 10 >> 4 > 5 ~ 6 ~ 2 >> 1 
MIF + 
molecular 
surface 
V ratio 10 > 6 > 7 > 2 > 1 > 4 > 9 > 5 8 and 3 
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a) 
 
b) 
Figure 1  
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Figure 2.  
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Figure 5.  
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Figure 6.  
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